To the Editor:
We have read with great interest the study by Singer et al. (1) and we would like to comment on the relationship between anti-müllerian hormone (AMH), follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels in polycystic ovary syndrome (PCOS). Read the rest of this entry »
To the Editor:
We read with interest the case report by Tocci reporting a live birth in a woman with a negligible anti-Mullerian hormone (AMH) as defined by an AMH of <3.5 pmol/L (1). We have previously reported a prospective cohort of 61 women with a median AMH of 3.0 (IQR 2.0 -3.8) pmol/L, where use of antagonist cycles without preprogramming achieved a clinical pregnancy rate of 14.7% per cycle started and a trend towards higher pregnancy rates as compared to agonist cycles [adjusted OR 2.89 (95% CI 0.88 -9.50); p=0.08](2). Read the rest of this entry »
